Schedule 13D ownership disclosure

Coherus Oncology Inc

Security class unavailable · CUSIP: 19249H103

Event date: 2016-02-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,949,829
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-111878
Form type
SC 13D/A
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Apr 15, 2016
Reporting period
Feb 29, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub